Skip to main content

Advertisement

Table 2 Comparisons of the percentages of CD3 + , CD4 + , CD8 + , and CD19 + lymphocytes in the death and survival groups and the long-term survival group (LTSG) and mid-term survival group (MTSG) using a mixed model

From: Biomarkers of early sepsis may be correlated with outcome

Survival Group versus Death Group LTSG versus MTSG
Variable Model-Based Test p Variable Model-Based Test p
   Estimated Mean*(SE)      Estimated Mean*(SE)   
CD3+ T    0.08 0.79 CD3+ T    0.55 0.47
  Survival 1.72 (0.04)     LTSG 1.74 (0.04)   
  Death 1.76 (0.06)     MTSG 1.70 (0.05)   
CD4+ T    0.24 0.63 CD4+ T    0.01 0.93
  Survival 1.43 (0.05)     LTSG 1.44 (0.06)   
  Death 1.48 (0.09)     MTSG 1.45 (0.07)   
CD8+ T    0.36 0.55 CD8+ T    0.05 0.83
  Survival 1.34 (0.06)     LTSG 1.34 (0.05)   
  Death 1.27 (0.09)     MTSG 1.36 (0.07)   
CD19+ B cell    3.63 0.07 CD19+ B cell    0.14 0.71
  Survival 1.17 (0.12)     LTSG 1.15 (0.07)   
  Death 0.67 (0.24)     MTSG 1.18 (0.08)   
  1. CD3+ T cells: the percentage of CD3+ T cells in lymphocytes; CD19+ B cells: the percentage of CD19+ B cells in lymphocytes.